Development of an intervention to manage benzodiazepine dependence and high-risk use in the context of escalating drug related deaths in Scotland: an application of the MRC framework

被引:2
作者
Berry, Karen [1 ]
Matheson, Catriona [1 ]
Schofield, Joe [2 ]
Dumbrell, Joshua [1 ]
Parkes, Tessa [1 ]
Hill, Duncan [3 ]
Kilonzo, Mary [4 ]
Maclennan, Graeme [4 ]
Stewart, Duncan [5 ]
Ritchie, Trina [6 ]
Turner, Michael [7 ]
机构
[1] Univ Stirling, Stirling, Scotland
[2] Univ Edinburgh, Edinburgh, Scotland
[3] NHS Lanarkshire, Bothwell, Lanks, Scotland
[4] Univ Aberdeen, Aberdeen, Scotland
[5] NHS Lothian, Edinburgh, Scotland
[6] NHS Greater Glasgow & Clyde, Glasgow, Scotland
[7] NHS Grampian, Aberdeen, Scotland
关键词
Intervention development; Co-production; Drug related deaths; Benzodiazepines; Opiates; PWLE; Polydrug use;
D O I
10.1186/s12913-023-10201-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundScotland has the highest rate of drug related deaths (DRD) in Europe. These are deaths in people who use drugs such as heroin, cocaine, benzodiazepines and gabapentinoids. It is a feature of deaths in Scotland that people use combinations of drugs which increases the chance of a DRD. Many deaths involve 'street' benzodiazepines, especially a drug called etizolam. Many of the 'street' benzodiazepines are not licensed in the UK so come from illegal sources. People who use opiates can be prescribed a safer replacement medication (e.g., methadone). While guidance on management of benzodiazepines use highlights that there is little evidence to support replacement prescribing, practice and evidence are emerging.AimTo develop an intervention to address 'street' benzodiazepines use in people who also use opiates.MethodsThe MRC Framework for Complex Interventions was used to inform research design. Co-production of the intervention was achieved through three online workshops with clinicians, academics working in the area of substance use, and people with lived experience (PWLE). Each workshop was followed by a PWLE group meeting. Outputs from workshops were discussed and refined by the PWLE group and then further explored at the next workshop.ResultsAfter these six sessions, a finalised logic model for the intervention was successfully achieved that was acceptable to clinicians and PWLE. Key components of the intervention were: prescribing of diazepam; anxiety management, sleep, and pain; and harm reduction resources (locked box and a range of tips), personal safety conversations, as well as a virtual learning environment.ConclusionA co-produced intervention was developed for next stage clinical feasibility testing.
引用
收藏
页数:11
相关论文
共 28 条
[1]   Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users [J].
Baandrup, Lone ;
Ebdrup, Bjorn H. ;
Rasmussen, Jesper O. ;
Lindschou, Jane ;
Gluud, Christian ;
Glenthoj, Birte Y. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (03)
[2]   Benzodiazepine maintenance in opiate substitution treatment: Good or bad? A retrospective primary care case-note review [J].
Bakker, Adam ;
Streel, Emmanuel .
JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (01) :62-66
[3]   Which medications are suitable for agonist drug maintenance? [J].
Darke, Shane ;
Farrell, Michael .
ADDICTION, 2016, 111 (05) :767-774
[4]  
Department of Health and Social Care: Department of Health and Social Care, 2017, Drug Misuse and Dependence: UK Guidelines on Clinical Management,
[5]  
European Monitoring Centre for Drugs and Drug Addiction, 2018, The misuse of benzodiazepines among high-risk opioid users in Europe
[6]  
European Monitoring Centre for Drugs and Drug Addiction, 2021, ACT FRAM DEV IMPL HL
[7]  
Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]
[8]   Benzodiazepines revisited-will we ever learn? [J].
Lader, Malcolm .
ADDICTION, 2011, 106 (12) :2086-2109
[9]   Harm Reduction Therapy: A Practice-Friendly Review of Research [J].
Logan, Diane E. ;
Marlatt, G. Alan .
JOURNAL OF CLINICAL PSYCHOLOGY, 2010, 66 (02) :201-214
[10]  
Macleod J, 2019, PLOS MED, V16, DOI [10.1371/journal.pmed.1002965, 10.1371/journal.pmed.1002965.r001, 10.1371/journal.pmed.1002965.r002, 10.1371/journal.pmed.1002965.r003, 10.1371/journal.pmed.1002965.r004, 10.1371/journal.pmed.1002965.r005]